9 Meters Biopharma Inc., a company focused on gastrointestinal (GI) diseases, plans to appeal the Nasdaq’s decision to delist its shares from the stock exchange, according to an 8-K filing with the Securities and Exchange Commission.
Read More
The patent is related to larazotide, the company’s proprietary investigational agent and potential approach to treating lung disease.
Read More
Named after the approximate length of the digestive track, 9 Meters focuses on specialty, rare and orphan gastrointestinal diseases.
Read More
If you were born with an abnormally short digestive tract, or had to have your bowel surgically shortened, a young Raleigh pharmaceutical company is developing a drug to help you regain lost nutritional benefit from food digestion.
Read More
Raleigh-based Innovate Biopharmaceuticals, a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases, has finalized its merger with Israeli-based RDD Pharma, a startup focused on orphan and innovative therapies for gastrointestinal disorders. The result: 9 Meters Biopharm
Read More
Raleigh clinical-stage pharmaceutical developer Innovate Biopharma is merging with Israel-based RDD Pharma to create a new company, 9 Meters Biopharma. Here’s a look inisde the deal.
Read More
